Skip to main content
. 2022 Jan 17;16(1):49–54. doi: 10.22074/IJFS.2021.523075.1074

Table 1.

Demographic data


Variables Control (n=25) Adenomyosis (n=25) Fibroid (n=25) P value (three-groupcomparison) P value (betweengroups)

Age (Y) 62.5 ± 15.5 48.1 ± 27.9 46.9 ± 16.1 <0.001 <0.001*,**
Endometrial pathology 0.001*,**
Proliferative 3(12) 16(64) 7(28) 0.001
Secretory 1(4) 2(8) 4(16)
Inactive 21(84) 6(24) 10940 2(8)
Progestin effect 0(0) 1(4)
Unknown 0(0) 0(0) 2(8)
Menopausal status <0.001*,**
Premenopausal 4(16) 20(80) 19(76) <0.001
Postmenopausal 21(84) 5(20) 6(24)
Parity
Null 5(20) 7(28) 9(36) 0.452
Parous 20(80) 18(72) 16(64
Type of surgery
Hysterectomy 25(100) 25(100) 23(92) <0.001 <0.001*,**
Excision 0(0) 0(0) 2(8)
Uterine volume, cm3 45.4 ± 48.2 219.5 ± 201.1 232.2 ± 187.3 <0.001 0.001* <0.001**
Type of adenomyosis N/A
Diffuse N/A 22(88) N/A
Focal 3(12)

Data are presented as mean ± SD. SD; Standard deviation, NA; Not available, *; Control vs. adenomyosis, **; Control vs. fibroid, and ***; Adenomyosis vs. fibroid.